Type 2 Diabetes Mellitus in Obese
Conditions
Brief summary
The purpose of this study is to evaluate the effect of a nutrient dense plant rich (NDPR) diet compared to a standard USDA diet on glycemic control, inflammation, and cardiovascular risk in individuals with type 2 diabetes and overweight/obesity.
Interventions
nutrient rich plant based diert
DASH diet
Sponsors
Study design
Eligibility
Inclusion criteria
1. Men and women ages 18-75 2. Type 2 diabetes mellitus diagnosed \> 6 months prior to screening visit according to American Diabetes Association criteria 3. HBA1c \>7.5% but \< 10% 4. BMI \>25 kg/m2 ; \>23 kg/m2 for Asian subjects but \< 45 kg/m2 5. Stable weight (variation \< 5 kg within 6 months of screening visit) 6. Ability to give informed consent 7. Ability to follow verbal and written instructions in English
Exclusion criteria
1. Active cardiac issues: history of myocardial infarction within 3 months of screening visit, unstable angina pectoris, or Class III or Class IV congestive heart failure 2. Persistent uncontrolled hypertension (BP \> 160/100 mmHg on or off antihypertensive medication) 3. Active marijuana or intravenous drug use 4. Recent weight loss (\> 5 kg within 6 months of the screening visit) 5. Inflammatory or irritable bowel disease (Crohn's Disease, Ulcerative Colitis, or IBS) 6. Celiac disease 7. Malignancy treated with chemotherapy within the past 1 year 8. Depression or psychosis requiring hospitalization within 1 year, or use of major antipsychotic or tranquilizer drugs (i.e. benzodiazepines) 9. Renal insufficiency (creatinine clearance \< 30 ml/min) 10. Transaminases \> 2x above the normal range 11. Pregnancy within 6 months of the screening visit 12. Lactation 13. History of surgery for the treatment of obesity (gastric banding, gastric bypass, gastric stapling 14. History of alcohol abuse within the past 5 years 15. Vegetarian/Vegan diet 16. Dairy Allergy/Intolerance 17. Anemia, including iron deficient and megaloblastic 18. Vitamin B12 deficiency 19. Leber's disease
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Glycemic control | change at 1, 3, 6, 9, 12 months | A1C and finger stick blood sugar levels |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| body weight | change at 1, 3, 6, 9, 12 months | — |
| body composition | change at 1,3,6,9, 12 months | DXA scan |
| hepatic steatosis | baseline, 1, 3, 6, 9, 12 months | MRspectroscopy |
| inflammatory markers | change at, 1, 3, 6, 9, 12 months | serum inflammatory markers |
| quality of life | change at, 1, 3, 6, 9, 12 months | validated questionnaired |
Countries
United States